| abstract |
Methods for diagnosing, monitoring, and screening diseases based on circulating rare cells, clusters, fragments and debris, including malignant diseases determined by CTC, and biological specimens using these methods Providing kits for assay. Limit, reduce, eliminate, or at least limit in vitro damage to prevent it from interfering with analysis, including flow cytometry and CellSpotter® fluorescence microscope imaging system Analyze circulating tumor cells, clusters, fragments and debris on multiple platforms. [Selection] Figure 1a |